Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth

S C Wong1, V E MacRae2, J A Gracie3

  • 1Bone and Endocrine Research Group, Department of Child Health, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8SJ, United Kingdom.

Insights

Children with juvenile idiopathic arthritis (JIA) experiencing mild growth retardation showed reduced levels of ALS and IGFBP-3. Interleukin-5 (IL5) and Interleukin-15 (IL15) were linked to short stature in JIA patients.

Area of Science:

  • Pediatric Endocrinology
  • Rheumatology
  • Immunology

Background:

  • Juvenile idiopathic arthritis (JIA) can impact physical growth.
  • Systemic markers of growth hormone (GH) secretion are crucial for monitoring growth in children.
  • Inflammation is a key feature of JIA and may influence growth and GH secretion.

Purpose of the Study:

  • To investigate the relationship between inflammation markers and physical growth in children with JIA.
  • To examine the association between inflammation markers and systemic markers of GH secretion in JIA.
  • To identify potential predictors of growth impairment in JIA.

Main Methods:

  • A cross-sectional prospective study involving 17 children with JIA undergoing therapeutic arthrocentesis.
  • Classification of patients into oligoarticular JIA (OJIA) and polyarticular JIA (PJIA) groups.
  • Measurement of adjusted height standard deviation score (AHt SDS), serum ALS SDS, IGFBP-3 SDS, IGF-1 SDS, and inflammatory cytokines (IL5, IL15).

Main Results:

  • Children with JIA exhibited a median AHt SDS of -0.3.
  • Reduced serum ALS SDS and IGFBP-3 SDS were observed.
  • Log serum IL5 and IL15 levels were independently associated with AHt SDS, indicating a link to short stature.

Conclusions:

  • Children with JIA and mild growth retardation demonstrate decreased ALS and IGFBP-3 levels.
  • While individual inflammatory cytokines did not associate with systemic GH secretion markers, IL5 and IL15 show a novel, preliminary association with the degree of short stature in JIA.
  • These findings suggest a potential role for specific cytokines in mediating growth impairment in JIA.
Abstract

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...